Severe COVID-19 in inflammatory bowel disease patients in a population-based setting.

Rob H CreemersAshkan Rezazadeh ArdabiliDaisy M JonkersMathie P G LeersMariëlle J Romberg-CampsMarie J PierikAd A van Bodegraven

Published in: PloS one (2021)

We found a statistically significant higher rate of hospitalization due to COVID-19 in IBD patients in a population-based setting in a heavily impacted Dutch region. This finding reflects previous research that showed IBD patients using systemic medication were at an increased risk of serious infection. However, although at an increased risk of hospitalization, clinical course of severe COVID-19 was comparable to hospitalized patients without IBD.

Keyphrases

end stage renal disease
coronavirus disease
sars cov
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
patient reported outcomes